• 9964432222
  • Mail Us
  • Appointment
  • Locate Us
  • Chat Now
  • Courses
  • Login
  • Register
Manifest IAS
JournalsOfIndia
Advertisement
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
JournalsOfIndia
No Result
View All Result
Home Society

 COVID-19 Treatment

June 26, 2020
in Society
Reading Time: 2 mins read
0
50
VIEWS
Share on WhatsAppShare on TelegramShare on Facebook

Since COVID-19 is a novel virus, there have been continuous efforts by the various health agencies to undertake trials of various drugs to find efficacy, safety of those. It has been work in progress, with scientists getting better understanding with greater experimentation.

Dexamethasone trial

  • Preliminary findings shared with WHO have shown that Dexamethasone, a corticosteroid (which closely mimic cortisol, the hormone naturally produced by the adrenal glands in humans), can be lifesaving for patients who are critically ill with COVID-19.
  • For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth.
  • The benefit however was only seen in patients seriously ill with COVID-19, and was not observed in patients with milder disease.
  • Dexamethasone is a steroid that has been used since the 1960s to reduce inflammation in a range of conditions, including inflammatory disorders and certain cancers.
  • It reduces the production of the chemicals that cause inflammation and also reduces the activity of the immune system by affecting the way white blood cells function.

Umifenovir Trial

  • The Central Drug Research Institute (CDRI), Lucknow, a constituent lab of the CSIR, has received permission for carrying out Phase III trials for the use of Umifenovir against COVID-19. It is found that the drug has a good safety profile and acts by preventing entry of the virus into human cells and also by priming the immune system.
  • Umifenovir is mainly used for the treatment of influenza. CSIR-CDRI has developed the process technology for Umifenovir and licensed the process technology for manufacturing and marketing the drug to Medizest Pharmaceuticals.

Favipiravir Trial

  • Glenmark Pharmaceuticals has received an approval from India’s drugs regulator to make and sell oral antiviral drug favipiravir for treating mild-to-moderate Covid-19 patients in the country.
  • Favipiravir is an antiviral drug and is also being used to treat new influenza viruses in Japan.

 

 

 

Tags: Prelims

Related Posts

Online census for Assamese Muslims

Online census for Assamese Muslims

April 16, 2021
Online grievance management portal by NCSC

Online grievance management portal by NCSC

April 16, 2021
MANAS Mitra

MANAS Mitra

April 15, 2021
Permanent Commission for Women : The SC rules the Annual Confidential Report Discriminatory

Permanent Commission for Women : The SC rules the Annual Confidential Report Discriminatory

April 6, 2021
Khasi Tribe

Khasi Tribe

April 6, 2021
Siddi Tribes

Siddi Tribes

April 5, 2021
Apatani tribe

Apatani tribe

March 30, 2021
Sanskritisation

Sanskritisation

March 30, 2021
Rohingya Muslims

Rohingya Muslims

March 29, 2021
SC Guidelines on Handling Cases of Sexual Crimes by the Judiciary

SC Guidelines on Handling Cases of Sexual Crimes by the Judiciary

March 26, 2021
Please login to join discussion
April 2021
MTWTFSS
 1234
567891011
12131415161718
19202122232425
2627282930 
« Mar    

Browse by Category

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Uncategorized

Browse by Tags

AIR DownToEarth Down to Earth GS-1 GS-2 GS-3 GS-4 India & the world Kurukshetra Mains news News Paper PIB Prelims PRS India RSTV Science Reporter Survey Yojana
JournalsOfIndia

Our vision is to orient the readers to grasp the facts objectively and analyse critically. In the rush of reaching first to the readers, the websites miss the balanced opinion, which is the need of the hour. We aim to reach the readers with more crispness, preciseness and relevance. We bring the articles in UPSC way for the civil services aspirants and the Wisest Way for general readers.

Categories

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Uncategorized

Browse by Tag

AIR DownToEarth Down to Earth GS-1 GS-2 GS-3 GS-4 India & the world Kurukshetra Mains news News Paper PIB Prelims PRS India RSTV Science Reporter Survey Yojana

Newsletter

The most important UPSC news and events of the day.

Get Journals daily newsletter on your inbox.

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

  • Login
  • Sign Up
  • Home
  • SNIPPETS
  • ARTICLES
  • BROWSE
  • DOWNLOADS
No Result
View All Result

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In